Perrigo and Catalent Announce FDA Approval of Perrigo's AB-rated Generic Version of ProAir® HFA
Go back to Perrigo and Catalent Announce FDA Approval of Perrigo's AB-rated Generic Version of ProAir® HFA| Perrigo (NYSE: PRGO) | Delayed: 16.21 +0.30 (1.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.91 | 52 Week High | $156.03 | |||
| Open | $15.99 | 52 Week Low | $79.72 | |||
| Day High | $16.34 | P/E | N/A | |||
| Day Low | $15.90 | EPS | $0.00 | |||
| Volume | 247,248 | |||||
| Perrigo (NYSE: PRGO) | Delayed: 16.21 +0.30 (1.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.91 | 52 Week High | $156.03 | |||
| Open | $15.99 | 52 Week Low | $79.72 | |||
| Day High | $16.34 | P/E | N/A | |||
| Day Low | $15.90 | EPS | $0.00 | |||
| Volume | 247,248 | |||||



